GlassScriptPhysician profile
Georgios Gkotsis
NPI 1922329630
$2,096.83
in general payments reported to CMS, 2019-2025
11 companies · $466 in 2025
The $466 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $426 · 2020: $316 · 2021: $272 · 2022: $39.48 · 2023: $209 · 2024: $369 · 2025: $466.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,043.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,043.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $904.55 | 2019-2021 | |
| Penumbra, INC. | $617.36 | 2023-2025 | Penumbra System, Indigo System |
| Boston Scientific Corporation | $175.66 | 2021-2025 | Opticross 35, Enroute Transcarotid Neuroprotection System |
| Medtronic, INC. | $167.76 | 2024 | Endurant Iis |
| Tactile Systems Technology INC | $83.28 | 2023 | Flexitouch Plus, Entre Plus |
| Cardiovascular Systems INC. | $38.62 | 2019-2020 | |
| Bolton Medical INC | $32.71 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $24.76 | 2024 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Silk Road Medical, INC. | $21.48 | 2022 | |
| Inari Medical, INC. | $18.00 | 2022 | |
| Teleflex LLC | $12.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Georgios Gkotsis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.